Influenza Specific Humoral and Cellular Immunity After Vaccination in Recipients of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
Most Recent Events
- 07 Nov 2017 Biomarkers information updated
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2012 Planned end date changed from 1 Aug 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.